Development of activated endothelial targeted high-density lipoprotein nanoparticles.

Front Pharmacol · 2022 · PMC9464908 · PMID 36105190

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Mice treated with VHPK-sHDLs presented lower plasma MCP-1 levels and showed a trend for lower IL-6 levels in plasma ( Figure 9A ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.